Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection

• Torben Knuschke,
• Olga Rotan,
• Wibke Bayer,
• Sebastian Kollenda,
• Julia Dickow,
• Kathrin Sutter,
• Wiebke Hansen,
• Ulf Dittmer,
• Karl S. Lang,
• Matthias Epple,
• Jan Buer,
• Astrid M. Westendorf

Affiliations

Torben Knuschke

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Olga Rotan

Institute of Inorganic Chemistry, Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, Essen, Germany

Wibke Bayer

Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Sebastian Kollenda

Institute of Inorganic Chemistry, Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, Essen, Germany

Julia Dickow

Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Kathrin Sutter

Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Wiebke Hansen

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Ulf Dittmer

Institute of Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Karl S. Lang

Institute for Immunology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Matthias Epple

Institute of Inorganic Chemistry, Center for Nanointegration Duisburg-Essen (CeNIDE), University of Duisburg-Essen, Essen, Germany

Jan Buer

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Astrid M. Westendorf

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany